New developments in the treatment of systemic vasculitis

Medicine and Dentistry

• Morbidity 50%
• Granulomatosis with Polyangiitis 50%
• Cyclophosphamide 50%
• Therapeutics 25%
• Disease Course 25%
• Relapse 25%
• Drug Megadose 25%
• Immunoglobulin 25%
• Low Drug Dose 25%
• Immunosuppressive Treatment 25%
• Spontaneous Remission 25%
• Glomerulonephritis 25%
• Cryoglobulinemia 25%
• Hypersensitivity Angiitis 25%
• Serine Proteinase 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Wegener Granulomatosis 50%
• Immunosuppressive Agent 25%
• Remission 25%
• Alpha Interferon 25%
• Kidney Disease 25%

Immunology and Microbiology

• CD4 25%
• Serine 25%
• Immunosuppressive Therapy 25%